Medications for Diabetic Retinopathy

4 results

  • Ahzantive (aflibercept-mrbb)

    (aflibercept-mrbb)
    Valorum Biologics Inc
    Usage: AHZANTIVE is indicated for the treatment of neovascular (wet) age-related macular degeneration, macular edema following retinal vein occlusion, diabetic macular edema, and diabetic retinopathy.

  • Cimerli

    (ranibizumab-eqrn)
    Coherus BioSciences Inc
    Usage: CIMERLI is indicated for treating neovascular (wet) age-related macular degeneration, macular edema following retinal vein occlusion, diabetic macular edema, diabetic retinopathy, and myopic choroidal neovascularization.

  • Eylea hd

    (aflibercept)
    Regeneron Pharmaceuticals, Inc
    Usage: EYLEA HD is indicated for the treatment of neovascular (wet) age-related macular degeneration (nAMD), diabetic macular edema (DME), and diabetic retinopathy (DR).

  • Lucentis

    (RANIBIZUMAB)
    Genentech, Inc.
    Usage: LUCENTIS is indicated for the treatment of neovascular (wet) age-related macular degeneration, macular edema following retinal vein occlusion, diabetic macular edema, diabetic retinopathy, and myopic choroidal neovascularization.